 | • レポートコード：MRC2-11QY08903 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はペット用医薬品のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗真菌剤、ノミ製品）市場規模、用途別（猫、犬、馬、魚、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ペット用医薬品の競争状況、市場シェア ・世界のペット用医薬品市場：種類別市場規模 2015年-2020年（抗生物質、抗真菌剤、ノミ製品） ・世界のペット用医薬品市場：種類別市場規模予測 2021年-2026年（抗生物質、抗真菌剤、ノミ製品） ・世界のペット用医薬品市場：用途別市場規模 2015年-2020年（猫、犬、馬、魚、その他） ・世界のペット用医薬品市場：用途別市場規模予測 2021年-2026年（猫、犬、馬、魚、その他） ・北米のペット用医薬品市場分析：米国、カナダ ・ヨーロッパのペット用医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのペット用医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のペット用医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのペット用医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Zoetis、Merck、Elanco、Bayer、Boehringer、Novartis、Virbac、Ceva、Vetoquinol、Nexvet、Aratana Therapeutics、Kindred Biosciences、Ambrx、Entest Biomedical、Taconic Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pet Medication Market
The global Pet Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pet Medication Scope and Market Size
Pet Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pet Medication market is segmented into
Antibiotics
Antifungal
Flea Products
Segment by Application, the Pet Medication market is segmented into
Cat
Dog
Horse
Fish
Other
Regional and Country-level Analysis
The Pet Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Medication Market Share Analysis
Pet Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Medication business, the date to enter into the Pet Medication market, Pet Medication product introduction, recent developments, etc.
The major vendors covered:
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
1 Study Coverage
1.1 Pet Medication Product Introduction
1.2 Market Segments
1.3 Key Pet Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Medication Market Size Growth Rate by Type
1.4.2 Antibiotics
1.4.3 Antifungal
1.4.4 Flea Products
1.5 Market by Application
1.5.1 Global Pet Medication Market Size Growth Rate by Application
1.5.2 Cat
1.5.3 Dog
1.5.4 Horse
1.5.5 Fish
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pet Medication Market Size, Estimates and Forecasts
2.1.1 Global Pet Medication Revenue 2015-2026
2.1.2 Global Pet Medication Sales 2015-2026
2.2 Global Pet Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pet Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pet Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pet Medication Competitor Landscape by Players
3.1 Pet Medication Sales by Manufacturers
3.1.1 Pet Medication Sales by Manufacturers (2015-2020)
3.1.2 Pet Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Pet Medication Revenue by Manufacturers
3.2.1 Pet Medication Revenue by Manufacturers (2015-2020)
3.2.2 Pet Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Medication Revenue in 2019
3.2.5 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pet Medication Price by Manufacturers
3.4 Pet Medication Manufacturing Base Distribution, Product Types
3.4.1 Pet Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Medication Product Type
3.4.3 Date of International Manufacturers Enter into Pet Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pet Medication Market Size by Type (2015-2020)
4.1.1 Global Pet Medication Sales by Type (2015-2020)
4.1.2 Global Pet Medication Revenue by Type (2015-2020)
4.1.3 Pet Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Medication Revenue Forecast by Type (2021-2026)
4.2.3 Pet Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pet Medication Market Size by Application (2015-2020)
5.1.1 Global Pet Medication Sales by Application (2015-2020)
5.1.2 Global Pet Medication Revenue by Application (2015-2020)
5.1.3 Pet Medication Price by Application (2015-2020)
5.2 Pet Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Medication Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pet Medication by Country
6.1.1 North America Pet Medication Sales by Country
6.1.2 North America Pet Medication Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pet Medication Market Facts & Figures by Type
6.3 North America Pet Medication Market Facts & Figures by Application
7 Europe
7.1 Europe Pet Medication by Country
7.1.1 Europe Pet Medication Sales by Country
7.1.2 Europe Pet Medication Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pet Medication Market Facts & Figures by Type
7.3 Europe Pet Medication Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pet Medication by Region
8.1.1 Asia Pacific Pet Medication Sales by Region
8.1.2 Asia Pacific Pet Medication Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pet Medication Market Facts & Figures by Type
8.3 Asia Pacific Pet Medication Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pet Medication by Country
9.1.1 Latin America Pet Medication Sales by Country
9.1.2 Latin America Pet Medication Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pet Medication Market Facts & Figures by Type
9.3 Central & South America Pet Medication Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pet Medication by Country
10.1.1 Middle East and Africa Pet Medication Sales by Country
10.1.2 Middle East and Africa Pet Medication Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pet Medication Market Facts & Figures by Type
10.3 Middle East and Africa Pet Medication Market Facts & Figures by Application
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Medication Products Offered
11.1.5 Zoetis Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Pet Medication Products Offered
11.2.5 Merck Related Developments
11.3 Elanco
11.3.1 Elanco Corporation Information
11.3.2 Elanco Description and Business Overview
11.3.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Elanco Pet Medication Products Offered
11.3.5 Elanco Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Pet Medication Products Offered
11.4.5 Bayer Related Developments
11.5 Boehringer
11.5.1 Boehringer Corporation Information
11.5.2 Boehringer Description and Business Overview
11.5.3 Boehringer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Pet Medication Products Offered
11.5.5 Boehringer Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Pet Medication Products Offered
11.6.5 Novartis Related Developments
11.7 Virbac
11.7.1 Virbac Corporation Information
11.7.2 Virbac Description and Business Overview
11.7.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Virbac Pet Medication Products Offered
11.7.5 Virbac Related Developments
11.8 Ceva
11.8.1 Ceva Corporation Information
11.8.2 Ceva Description and Business Overview
11.8.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ceva Pet Medication Products Offered
11.8.5 Ceva Related Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Corporation Information
11.9.2 Vetoquinol Description and Business Overview
11.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vetoquinol Pet Medication Products Offered
11.9.5 Vetoquinol Related Developments
11.10 Nexvet
11.10.1 Nexvet Corporation Information
11.10.2 Nexvet Description and Business Overview
11.10.3 Nexvet Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Nexvet Pet Medication Products Offered
11.10.5 Nexvet Related Developments
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Description and Business Overview
11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Zoetis Pet Medication Products Offered
11.1.5 Zoetis Related Developments
11.12 Kindred Biosciences
11.12.1 Kindred Biosciences Corporation Information
11.12.2 Kindred Biosciences Description and Business Overview
11.12.3 Kindred Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kindred Biosciences Products Offered
11.12.5 Kindred Biosciences Related Developments
11.13 Ambrx
11.13.1 Ambrx Corporation Information
11.13.2 Ambrx Description and Business Overview
11.13.3 Ambrx Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Ambrx Products Offered
11.13.5 Ambrx Related Developments
11.14 Entest Biomedical
11.14.1 Entest Biomedical Corporation Information
11.14.2 Entest Biomedical Description and Business Overview
11.14.3 Entest Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Entest Biomedical Products Offered
11.14.5 Entest Biomedical Related Developments
11.15 Taconic Biosciences
11.15.1 Taconic Biosciences Corporation Information
11.15.2 Taconic Biosciences Description and Business Overview
11.15.3 Taconic Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Taconic Biosciences Products Offered
11.15.5 Taconic Biosciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pet Medication Market Estimates and Projections by Region
12.1.1 Global Pet Medication Sales Forecast by Regions 2021-2026
12.1.2 Global Pet Medication Revenue Forecast by Regions 2021-2026
12.2 North America Pet Medication Market Size Forecast (2021-2026)
12.2.1 North America: Pet Medication Sales Forecast (2021-2026)
12.2.2 North America: Pet Medication Revenue Forecast (2021-2026)
12.2.3 North America: Pet Medication Market Size Forecast by Country (2021-2026)
12.3 Europe Pet Medication Market Size Forecast (2021-2026)
12.3.1 Europe: Pet Medication Sales Forecast (2021-2026)
12.3.2 Europe: Pet Medication Revenue Forecast (2021-2026)
12.3.3 Europe: Pet Medication Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pet Medication Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pet Medication Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pet Medication Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pet Medication Market Size Forecast by Region (2021-2026)
12.5 Latin America Pet Medication Market Size Forecast (2021-2026)
12.5.1 Latin America: Pet Medication Sales Forecast (2021-2026)
12.5.2 Latin America: Pet Medication Revenue Forecast (2021-2026)
12.5.3 Latin America: Pet Medication Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pet Medication Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pet Medication Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pet Medication Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pet Medication Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pet Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pet Medication Market Segments
Table 2. Ranking of Global Top Pet Medication Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Medication Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antibiotics
Table 5. Major Manufacturers of Antifungal
Table 6. Major Manufacturers of Flea Products
Table 7. Global Pet Medication Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Pet Medication Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Pet Medication Sales by Regions 2015-2020 (K MT)
Table 10. Global Pet Medication Sales Market Share by Regions (2015-2020)
Table 11. Global Pet Medication Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pet Medication Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Pet Medication Sales Share by Manufacturers (2015-2020)
Table 14. Global Pet Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pet Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Medication as of 2019)
Table 16. Pet Medication Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pet Medication Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pet Medication Price (2015-2020) (USD/MT)
Table 19. Pet Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pet Medication Product Type
Table 21. Date of International Manufacturers Enter into Pet Medication Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pet Medication Sales by Type (2015-2020) (K MT)
Table 24. Global Pet Medication Sales Share by Type (2015-2020)
Table 25. Global Pet Medication Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pet Medication Revenue Share by Type (2015-2020)
Table 27. Pet Medication Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Pet Medication Sales by Application (2015-2020) (K MT)
Table 29. Global Pet Medication Sales Share by Application (2015-2020)
Table 30. North America Pet Medication Sales by Country (2015-2020) (K MT)
Table 31. North America Pet Medication Sales Market Share by Country (2015-2020)
Table 32. North America Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Pet Medication Revenue Market Share by Country (2015-2020)
Table 34. North America Pet Medication Sales by Type (2015-2020) (K MT)
Table 35. North America Pet Medication Sales Market Share by Type (2015-2020)
Table 36. North America Pet Medication Sales by Application (2015-2020) (K MT)
Table 37. North America Pet Medication Sales Market Share by Application (2015-2020)
Table 38. Europe Pet Medication Sales by Country (2015-2020) (K MT)
Table 39. Europe Pet Medication Sales Market Share by Country (2015-2020)
Table 40. Europe Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Pet Medication Revenue Market Share by Country (2015-2020)
Table 42. Europe Pet Medication Sales by Type (2015-2020) (K MT)
Table 43. Europe Pet Medication Sales Market Share by Type (2015-2020)
Table 44. Europe Pet Medication Sales by Application (2015-2020) (K MT)
Table 45. Europe Pet Medication Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Pet Medication Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Pet Medication Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Pet Medication Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Pet Medication Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Pet Medication Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Pet Medication Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Pet Medication Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Pet Medication Sales Market Share by Application (2015-2020)
Table 54. Latin America Pet Medication Sales by Country (2015-2020) (K MT)
Table 55. Latin America Pet Medication Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Pet Medication Revenue Market Share by Country (2015-2020)
Table 58. Latin America Pet Medication Sales by Type (2015-2020) (K MT)
Table 59. Latin America Pet Medication Sales Market Share by Type (2015-2020)
Table 60. Latin America Pet Medication Sales by Application (2015-2020) (K MT)
Table 61. Latin America Pet Medication Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Pet Medication Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Pet Medication Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Pet Medication Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pet Medication Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Pet Medication Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Pet Medication Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Pet Medication Sales Market Share by Application (2015-2020)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Major Businesses
Table 72. Zoetis Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Zoetis Product
Table 74. Zoetis Recent Development
Table 75. Merck Corporation Information
Table 76. Merck Description and Major Businesses
Table 77. Merck Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck Product
Table 79. Merck Recent Development
Table 80. Elanco Corporation Information
Table 81. Elanco Description and Major Businesses
Table 82. Elanco Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Elanco Product
Table 84. Elanco Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Boehringer Corporation Information
Table 91. Boehringer Description and Major Businesses
Table 92. Boehringer Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Boehringer Product
Table 94. Boehringer Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Major Businesses
Table 97. Novartis Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Virbac Corporation Information
Table 101. Virbac Description and Major Businesses
Table 102. Virbac Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Virbac Product
Table 104. Virbac Recent Development
Table 105. Ceva Corporation Information
Table 106. Ceva Description and Major Businesses
Table 107. Ceva Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Ceva Product
Table 109. Ceva Recent Development
Table 110. Vetoquinol Corporation Information
Table 111. Vetoquinol Description and Major Businesses
Table 112. Vetoquinol Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Vetoquinol Product
Table 114. Vetoquinol Recent Development
Table 115. Nexvet Corporation Information
Table 116. Nexvet Description and Major Businesses
Table 117. Nexvet Pet Medication Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Nexvet Product
Table 119. Nexvet Recent Development
Table 120. Aratana Therapeutics Corporation Information
Table 121. Aratana Therapeutics Description and Major Businesses
Table 122. Aratana Therapeutics Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Aratana Therapeutics Product
Table 124. Aratana Therapeutics Recent Development
Table 125. Kindred Biosciences Corporation Information
Table 126. Kindred Biosciences Description and Major Businesses
Table 127. Kindred Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Kindred Biosciences Product
Table 129. Kindred Biosciences Recent Development
Table 130. Ambrx Corporation Information
Table 131. Ambrx Description and Major Businesses
Table 132. Ambrx Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Ambrx Product
Table 134. Ambrx Recent Development
Table 135. Entest Biomedical Corporation Information
Table 136. Entest Biomedical Description and Major Businesses
Table 137. Entest Biomedical Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Entest Biomedical Product
Table 139. Entest Biomedical Recent Development
Table 140. Taconic Biosciences Corporation Information
Table 141. Taconic Biosciences Description and Major Businesses
Table 142. Taconic Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Taconic Biosciences Product
Table 144. Taconic Biosciences Recent Development
Table 145. Global Pet Medication Sales Forecast by Regions (2021-2026) (K MT)
Table 146. Global Pet Medication Sales Market Share Forecast by Regions (2021-2026)
Table 147. Global Pet Medication Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 148. Global Pet Medication Revenue Market Share Forecast by Regions (2021-2026)
Table 149. North America: Pet Medication Sales Forecast by Country (2021-2026) (K MT)
Table 150. North America: Pet Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Europe: Pet Medication Sales Forecast by Country (2021-2026) (K MT)
Table 152. Europe: Pet Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Asia Pacific: Pet Medication Sales Forecast by Region (2021-2026) (K MT)
Table 154. Asia Pacific: Pet Medication Revenue Forecast by Region (2021-2026) (US$ Million)
Table 155. Latin America: Pet Medication Sales Forecast by Country (2021-2026) (K MT)
Table 156. Latin America: Pet Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Middle East and Africa: Pet Medication Sales Forecast by Country (2021-2026) (K MT)
Table 158. Middle East and Africa: Pet Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 160. Key Challenges
Table 161. Market Risks
Table 162. Main Points Interviewed from Key Pet Medication Players
Table 163. Pet Medication Customers List
Table 164. Pet Medication Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Medication Product Picture
Figure 2. Global Pet Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Antibiotics Product Picture
Figure 4. Antifungal Product Picture
Figure 5. Flea Products Product Picture
Figure 6. Global Pet Medication Sales Market Share by Application in 2020 & 2026
Figure 7. Cat
Figure 8. Dog
Figure 9. Horse
Figure 10. Fish
Figure 11. Other
Figure 12. Pet Medication Report Years Considered
Figure 13. Global Pet Medication Market Size 2015-2026 (US$ Million)
Figure 14. Global Pet Medication Sales 2015-2026 (K MT)
Figure 15. Global Pet Medication Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Pet Medication Sales Market Share by Region (2015-2020)
Figure 17. Global Pet Medication Sales Market Share by Region in 2019
Figure 18. Global Pet Medication Revenue Market Share by Region (2015-2020)
Figure 19. Global Pet Medication Revenue Market Share by Region in 2019
Figure 20. Global Pet Medication Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Pet Medication Revenue in 2019
Figure 22. Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Pet Medication Sales Market Share by Type (2015-2020)
Figure 24. Global Pet Medication Sales Market Share by Type in 2019
Figure 25. Global Pet Medication Revenue Market Share by Type (2015-2020)
Figure 26. Global Pet Medication Revenue Market Share by Type in 2019
Figure 27. Global Pet Medication Market Share by Price Range (2015-2020)
Figure 28. Global Pet Medication Sales Market Share by Application (2015-2020)
Figure 29. Global Pet Medication Sales Market Share by Application in 2019
Figure 30. Global Pet Medication Revenue Market Share by Application (2015-2020)
Figure 31. Global Pet Medication Revenue Market Share by Application in 2019
Figure 32. North America Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Pet Medication Sales Market Share by Country in 2019
Figure 35. North America Pet Medication Revenue Market Share by Country in 2019
Figure 36. U.S. Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Pet Medication Market Share by Type in 2019
Figure 41. North America Pet Medication Market Share by Application in 2019
Figure 42. Europe Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Pet Medication Sales Market Share by Country in 2019
Figure 45. Europe Pet Medication Revenue Market Share by Country in 2019
Figure 46. Germany Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Pet Medication Market Share by Type in 2019
Figure 57. Europe Pet Medication Market Share by Application in 2019
Figure 58. Asia Pacific Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Pet Medication Sales Market Share by Region in 2019
Figure 61. Asia Pacific Pet Medication Revenue Market Share by Region in 2019
Figure 62. China Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Pet Medication Market Share by Type in 2019
Figure 85. Asia Pacific Pet Medication Market Share by Application in 2019
Figure 86. Latin America Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Pet Medication Sales Market Share by Country in 2019
Figure 89. Latin America Pet Medication Revenue Market Share by Country in 2019
Figure 90. Mexico Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Pet Medication Market Share by Type in 2019
Figure 97. Latin America Pet Medication Market Share by Application in 2019
Figure 98. Middle East and Africa Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Pet Medication Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Pet Medication Revenue Market Share by Country in 2019
Figure 102. Turkey Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Pet Medication Market Share by Type in 2019
Figure 109. Middle East and Africa Pet Medication Market Share by Application in 2019
Figure 110. North America Pet Medication Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Pet Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Pet Medication Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Pet Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Pet Medication Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Pet Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Pet Medication Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Pet Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Pet Medication Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Pet Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
薬物療法管理の世界市場（～2026年） Medication therapy management, generally called medicine use review in the United kingdom, is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing educ…- 自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…
- 抗マラリア薬の世界市場（～2026年） Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. viva…
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…
- 不眠症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Insomnia Medication Market The global Insomnia Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insomnia Medication Scope and Market Size Insomnia Medication market is seg…